Ms. Stallard serves as vice president of corporate quality and operational effectiveness, where she is the strategic leader of systemwide corporate quality programs and performance improvement initiatives at Orlando Health. In this role, she oversees all aspects of clinical quality and patient safety, including infection prevention, in support of the organization’s Embrace Quality and Safety strategic imperatives. While leading the transformation of Orlando Health’s infection prevention department, her efforts led to the achievement of year-over-year reductions. Most recently, during fiscal year 2023 to date, the organization reduced CLABSI by 50 percent and C. difficile by 46 percent.
